Aster Capital Management’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$35.2K Buy
2025
Q2
Sell
2025
Q1
$6.1K Buy
2024
Q4
$7.07K Sell
2024
Q3
$108K Buy